Regeneron Pharmaceuticals Stock Price History
| REGN Stock | USD 906.54 0.00 0.00% |
Below is the normalized historical share price chart for Regeneron Pharmaceuticals extending back to April 02, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Regeneron Pharmaceuticals stands at 906.54, as last reported on the 25th of April, with the highest price reaching 915.70 and the lowest price hitting 904.41 during the day.
If you're considering investing in Regeneron Stock, it is important to understand the factors that can impact its price. Regeneron Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0607, which implies the firm had a -0.0607% return per unit of risk over the last 3 months. Regeneron Pharmaceuticals exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Regeneron Pharmaceuticals' Variance of 0.8197, risk adjusted performance of (0.02), and Coefficient Of Variation of (2,328) to confirm the risk estimate we provide.
At this time, Regeneron Pharmaceuticals' Total Stockholder Equity is very stable compared to the past year. As of the 25th of April 2024, Liabilities And Stockholders Equity is likely to grow to about 34.7 B, while Common Stock Shares Outstanding is likely to drop about 75.4 M. . At this time, Regeneron Pharmaceuticals' Price Fair Value is very stable compared to the past year. Regeneron Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 2nd of April 1991 | 200 Day MA 861.2706 | 50 Day MA 950.9474 | Beta 0.141 |
Regeneron |
Sharpe Ratio = -0.0607
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | REGN |
Estimated Market Risk
| 0.9 actual daily | 7 93% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Regeneron Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Regeneron Pharmaceuticals by adding Regeneron Pharmaceuticals to a well-diversified portfolio.
Price Book 3.8232 | Enterprise Value Ebitda 19.4231 | Price Sales 7.5703 | Shares Float 102.8 M | Wall Street Target Price 1 K |
Regeneron Pharmaceuticals Stock Price History Chart
There are several ways to analyze Regeneron Stock price data. The simplest method is using a basic Regeneron candlestick price chart, which shows Regeneron Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 27, 2024 | 993.35 |
| Lowest Price | April 18, 2024 | 893.99 |
Regeneron Pharmaceuticals April 25, 2024 Stock Price Synopsis
Various analyses of Regeneron Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Regeneron Stock. It can be used to describe the percentage change in the price of Regeneron Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Regeneron Stock.| Regeneron Pharmaceuticals Accumulation Distribution | 4,605 | |
| Regeneron Pharmaceuticals Price Rate Of Daily Change | 1.00 | |
| Regeneron Pharmaceuticals Price Action Indicator | (3.52) |
Regeneron Pharmaceuticals April 25, 2024 Stock Price Analysis
Regeneron Stock Price History Data
The price series of Regeneron Pharmaceuticals for the period between Fri, Jan 26, 2024 and Thu, Apr 25, 2024 has a statistical range of 99.36 with a coefficient of variation of 2.48. The price distribution for the period has arithmetic mean of 949.83. The median price for the last 90 days is 954.58.| Open | High | Low | Close | Volume | ||
| 04/24/2024 | 907.32 | 915.70 | 904.41 | 906.54 | 373,468 | |
| 04/23/2024 | 905.66 | 912.74 | 903.83 | 907.32 | 340,941 | |
| 04/22/2024 | 904.54 | 908.50 | 897.68 | 900.16 | 335,757 | |
| 04/19/2024 | 914.99 | 920.73 | 891.46 | 896.82 | 501,396 | |
| 04/18/2024 | 901.26 | 908.81 | 892.15 | 893.99 | 446,333 | |
| 04/17/2024 | 903.88 | 911.64 | 899.90 | 901.19 | 466,918 | |
| 04/16/2024 | 897.22 | 901.07 | 890.43 | 894.14 | 608,464 | |
| 04/15/2024 | 915.37 | 921.12 | 895.09 | 898.56 | 656,152 | |
| 04/12/2024 | 911.55 | 912.22 | 898.26 | 904.70 | 665,300 | |
| 04/11/2024 | 928.58 | 930.64 | 907.33 | 920.32 | 617,045 | |
| 04/10/2024 | 935.02 | 937.87 | 923.44 | 936.20 | 388,700 | |
| 04/09/2024 | 941.39 | 949.20 | 938.00 | 943.89 | 305,700 | |
| 04/08/2024 | 939.16 | 942.99 | 935.51 | 938.48 | 323,445 | |
| 04/05/2024 | 939.31 | 949.83 | 934.87 | 942.70 | 353,353 | |
| 04/04/2024 | 962.20 | 962.20 | 935.36 | 937.02 | 403,617 | |
| 04/03/2024 | 954.68 | 961.68 | 950.43 | 950.95 | 390,005 | |
| 04/02/2024 | 961.44 | 961.44 | 951.02 | 954.68 | 411,004 | |
| 04/01/2024 | 964.73 | 970.20 | 954.09 | 969.31 | 338,071 | |
| 03/28/2024 | 970.38 | 970.79 | 959.25 | 962.49 | 446,659 | |
| 03/27/2024 | 971.04 | 976.75 | 962.41 | 966.30 | 309,697 | |
| 03/26/2024 | 961.99 | 966.68 | 957.78 | 963.55 | 379,832 | |
| 03/25/2024 | 954.01 | 964.98 | 952.47 | 961.09 | 315,100 | |
| 03/22/2024 | 973.00 | 977.39 | 966.47 | 967.24 | 265,931 | |
| 03/21/2024 | 974.75 | 979.26 | 968.00 | 968.01 | 427,433 | |
| 03/20/2024 | 959.06 | 967.20 | 947.37 | 966.96 | 579,114 | |
| 03/19/2024 | 965.11 | 969.16 | 959.14 | 963.66 | 365,317 | |
| 03/18/2024 | 970.00 | 970.71 | 959.49 | 959.92 | 360,091 | |
| 03/15/2024 | 956.47 | 968.51 | 953.72 | 964.47 | 1,071,151 | |
| 03/14/2024 | 966.30 | 969.18 | 950.97 | 959.04 | 501,731 | |
| 03/13/2024 | 979.82 | 979.82 | 963.83 | 965.47 | 386,200 | |
| 03/12/2024 | 964.44 | 975.93 | 963.51 | 970.57 | 359,022 | |
| 03/11/2024 | 971.09 | 979.80 | 960.44 | 964.44 | 355,600 | |
| 03/08/2024 | 973.34 | 976.00 | 962.82 | 968.83 | 303,096 | |
| 03/07/2024 | 971.13 | 979.25 | 969.96 | 973.31 | 369,733 | |
| 03/06/2024 | 959.23 | 974.17 | 955.56 | 972.10 | 358,004 | |
| 03/05/2024 | 972.72 | 977.67 | 953.29 | 965.21 | 392,906 | |
| 03/04/2024 | 982.82 | 983.51 | 966.22 | 971.19 | 455,588 | |
| 03/01/2024 | 967.50 | 988.04 | 966.09 | 982.82 | 370,528 | |
| 02/29/2024 | 989.91 | 990.30 | 965.16 | 966.09 | 785,919 | |
| 02/28/2024 | 995.00 | 998.32 | 987.61 | 987.61 | 485,920 | |
| 02/27/2024 | 989.00 | 995.23 | 975.40 | 993.35 | 461,517 | |
| 02/26/2024 | 977.55 | 995.97 | 975.00 | 989.28 | 541,290 | |
| 02/23/2024 | 975.00 | 985.64 | 969.15 | 981.20 | 439,552 | |
| 02/22/2024 | 953.57 | 973.00 | 947.85 | 964.89 | 599,934 | |
| 02/21/2024 | 952.00 | 957.90 | 945.70 | 952.84 | 300,457 | |
| 02/20/2024 | 950.00 | 963.00 | 943.73 | 946.87 | 417,730 | |
| 02/16/2024 | 953.44 | 956.49 | 944.13 | 948.05 | 367,431 | |
| 02/15/2024 | 951.67 | 958.74 | 949.09 | 954.73 | 332,419 | |
| 02/14/2024 | 943.10 | 951.83 | 936.70 | 947.82 | 373,517 | |
| 02/13/2024 | 946.17 | 947.46 | 933.80 | 940.48 | 523,811 | |
| 02/12/2024 | 952.39 | 954.53 | 941.01 | 947.06 | 446,000 | |
| 02/09/2024 | 948.00 | 957.51 | 945.85 | 953.42 | 512,870 | |
| 02/08/2024 | 934.79 | 947.23 | 930.04 | 946.43 | 458,110 | |
| 02/07/2024 | 940.00 | 954.30 | 933.46 | 938.49 | 455,030 | |
| 02/06/2024 | 940.00 | 945.46 | 927.52 | 937.81 | 460,430 | |
| 02/05/2024 | 931.87 | 939.50 | 923.03 | 936.33 | 703,800 | |
| 02/02/2024 | 971.23 | 973.99 | 939.31 | 945.18 | 751,680 | |
| 02/01/2024 | 945.61 | 964.93 | 938.39 | 957.78 | 517,540 | |
| 01/31/2024 | 961.05 | 965.66 | 941.19 | 942.78 | 601,530 | |
| 01/30/2024 | 956.00 | 960.21 | 945.85 | 959.73 | 365,270 | |
| 01/29/2024 | 946.12 | 957.67 | 943.84 | 955.80 | 525,050 |
About Regeneron Pharmaceuticals Stock history
Regeneron Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Regeneron is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Regeneron Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Regeneron Pharmaceuticals stock prices may prove useful in developing a viable investing in Regeneron Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 113.7 M | 75.4 M | |
| Net Income Applicable To Common Shares | 5 B | 5.2 B |
Regeneron Pharmaceuticals Quarterly Net Working Capital |
|
Regeneron Pharmaceuticals Stock Technical Analysis
Regeneron Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Regeneron Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Regeneron Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Regeneron Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Regeneron to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.17) | |||
| Treynor Ratio | (0.06) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regeneron Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Regeneron Stock analysis
When running Regeneron Pharmaceuticals' price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is Regeneron Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.03) | Earnings Share 34.73 | Revenue Per Share 122.935 | Quarterly Revenue Growth 0.006 | Return On Assets 0.0849 |
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.